Stage III Non-Small Cell Lung Cancer

Stage III Non-Small Cell Lung Cancer

CONDITION

Cancer

GENDER

Both males and females

AGE GROUP

18 years and above

TRIAL STATUS

Not yet recruiting

This study for patients with Stage III non-small cell lung cancer seeks to assess whether the addition of oral veliparib versus placebo to Paclitaxel/Carboplatin-based chemoradiotherapy with Paclitaxel/Carboplatin consolidation will improve progression-free survival.

CONTACT DETAILS

Phone Number: (08) 9446 8726
Email: info@affinityresearch.com.au
Location: 55/85 Monash Avenue, Nedlands, Western Australia, Australia

CONTACT SITE

Approved By: Hollywood Private Hospital Research Ethics Committee              

Clinical Trial Registry Link: